Theo Gulen

Publikationer
CV
Populärvetenskap och samverkan

Utvalda publikationer

Journal article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2024;12(3):753-761

Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.

Zaghmout T; Maclachlan L; Bedi N; Gülen T
Journal article: DIAGNOSTICS. 2023;13(24):3662

Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders.

Beyens M; Toscano A; Ebo D; Gülen T; Sabato V
Journal article: IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. 2023;43(4):681-698

Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.

Gulen T
Journal article: DIAGNOSTICS. 2023;13(21):3307

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis.

Gülen T
Journal article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2023;11(10):3010-3020

The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.

Valent P; Hoermann G; Bonadonna P; Hartmann K; Sperr WR; Broesby-Olsen S; Brockow K; Niedoszytko M; Hermine O; Chantran Y; Butterfield JH; Greiner G; Carter MC; Sabato V; Radia DH; Siebenhaar F; Triggiani M; Gülen T; Alvarez-Twose I; Staudinger T; Traby L; Sotlar K; Reiter A; Horny H-P; Orfao A; Galli SJ; Schwartz LB; Lyons JJ; Gotlib J; Metcalfe DD; Arock M; Akin C
Journal article: DIAGNOSTICS. 2023;13(13):2241

Diagnostic Evaluation of Hypersensitivity Reactions to Antibiotics in a Large Cohort of Mastocytosis Patients.

Jarkvist J; Gülen T
Article: BLOOD ADVANCES. 2023;7(9):1713-1724

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.

Kennedy VE; Perkins C; Reiter A; Jawhar M; Lübke J; Kluin-Nelemans HC; Shomali W; Langford C; Abuel J; Hermine O; Niedoszytko M; Gorska A; Mital A; Bonadonna P; Zanotti R; Tanasi I; Mattsson M; Hagglund H; Triggiani M; Yavuz AS; Panse J; Christen D; Heizmann M; Shoumariyeh K; Müller S; Elena C; Malcovati L; Fiorelli N; Wortmann F; Vucinic V; Brockow K; Fokoloros C; Papageorgiou SG; Breynaert C; Bullens D; Doubek M; Ilerhaus A; Angelova-Fischer I; Solomianyi O; Várkonyi J; Sabato V; Rüfer A; Schug TD; Hermans MAW; Fortina AB; Caroppo F; Bumbea H; Gulen T; Hartmann K; Elberink HO; Schwaab J; Arock M; Valent P; Sperr WR; Gotlib J
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2022;88(11):4845-4853

Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses.

Kowalik A; de Monestrol I; Sorjonen K; Brockow K; Gülen T
Article: CANCERS. 2022;14(16):3942

Clinical Outcomes of Adults with Systemic Mastocytosis: A 15-Year Multidisciplinary Experience.

Ungerstedt J; Ljung C; Klimkowska M; Gülen T
Article: ALLERGY. 2022;77(8):2292-2312

Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.

Barbaud A; Garvey LH; Arcolaci A; Brockow K; Mori F; Mayorga C; Bonadonna P; Atanaskovic-Markovic M; Moral L; Zanoni G; Pagani M; Soria A; Jošt M; Caubet J-C; Carmo A; Mona A-A; Alvarez-Perea A; Bavbek S; Benedetta B; Bilo MB; Blanca-López N; Bogas HG; Buonomo A; Calogiuri G; Carli G; Cernadas J; Cortellini G; Celik G; Demir S; Doña I; Dursun AB; Eberlein B; Faria E; Fernandes B; Garcez T; Garcia-Nunez I; Gawlik R; Gelincik A; Gomes E; Gooi JHC; Grosber M; Gülen T; Hacard F; Hoarau C; Janson C; Johnston SL; Joerg L; Kepil Özdemir S; Klimek L; Košnik M; Kowalski ML; Kuyucu S; Kvedariene V; Laguna JJ; Lombardo C; Marinho S; Merk H; Meucci E; Morisset M; Munoz-Cano R; Murzilli F; Nakonechna A; Popescu F-D; Porebski G; Radice A; Regateiro FS; Röckmann H; Romano A; Sargur R; Sastre J; Scherer Hofmeier K; Sedláčková L; Sobotkova M; Terreehorst I; Treudler R; Walusiak-Skorupa J; Wedi B; Wöhrl S; Zidarn M; Zuberbier T; Agache I; Torres MJ
Review: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2022;10(8):1941-1950

Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium.

Valent P; Hartmann K; Bonadonna P; Gülen T; Brockow K; Alvarez-Twose I; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Butterfield JH; Lyons JJ; Sperr WR; Greiner G; Sotlar K; Kluin-Nelemans HC; Schwaab J; Lange M; George TI; Siebenhaar F; Broesby-Olsen S; Jawhar M; Nedoszytko B; Castells M; Orfao A; Gotlib J; Reiter A; Horny H-P; Triggiani M; Arock M; Metcalfe DD; Akin C
Letter: ALLERGY. 2022;77(6):1909-1911

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity.

Lyberg K; Ekoff M; Westerberg CM; Engblom C; Dahlén B; Gülen T; Nilsson G
Letter: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2022;10(5):1377-1379

COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.

Lazarinis N; Bossios A; Gülen T
Article: IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. 2022;42(1):45-63

Anaphylaxis and Mast Cell Disorders.

Gülen T; Akin C
Article: FRONTIERS IN ALLERGY. 2022;3:1071807

Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: A two-center retrospective cohort study.

Bonadonna P; Olivieri F; Jarkvist J; Nalin F; Zanotti R; Maclachlan L; Gülen T
Review: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2021;9(11):3918-3928

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review.

Gülen T; Akin C; Bonadonna P; Siebenhaar F; Broesby-Olsen S; Brockow K; Niedoszytko M; Nedoszytko B; Oude Elberink HNG; Butterfield JH; Sperr WR; Alvarez-Twose I; Horny H-P; Sotlar K; Schwaab J; Jawhar M; Zanotti R; Nilsson G; Lyons JJ; Carter MC; George TI; Hermine O; Gotlib J; Orfao A; Triggiani M; Reiter A; Hartmann K; Castells M; Arock M; Schwartz LB; Metcalfe DD; Valent P
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2021;148(3):889-894

Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis.

Gülen T; Teufelberger A; Ekoff M; Westerberg CM; Lyberg K; Dahlén S-E; Dahlén B; Nilsson G
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2021;9(6):2139-2144

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).

Bonadonna P; Brockow K; Niedoszytko M; Elberink HO; Akin C; Nedoszytko B; Butterfield JH; Alvarez-Twose I; Sotlar K; Schwaab J; Jawhar M; Castells M; Sperr WR; Hermine O; Gotlib J; Zanotti R; Reiter A; Broesby-Olsen S; Bindslev-Jensen C; Schwartz LB; Horny H-P; Radia D; Triggiani M; Sabato V; Carter MC; Siebenhaar F; Orfao A; Grattan C; Metcalfe DD; Arock M; Gulen T; Hartmann K; Valent P
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2020;8(9):3093-3101

Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis.

Jarkvist J; Brockow K; Gülen T
Article: ALLERGY. 2020;75(1):169-177

Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection.

Jarkvist J; Salehi C; Akin C; Gülen T
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2017;5(5):1248-1255

Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis.

Gülen T; Ljung C; Nilsson G; Akin C
Review: CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. 2017;17(4):295-303

Pharmacotherapy of mast cell disorders.

Gülen T; Akin C
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2017;47(7):909-917

Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.

Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén S-E; Nilsson G; Dahlén B
Letter: LEUKEMIA. 2016;30(9):1953-1956

Detection of circulating mast cells in advanced systemic mastocytosis.

Dahlin JS; Ungerstedt JS; Grootens J; Sander B; Gülen T; Hägglund H; Nilsson G
Review: JOURNAL OF INTERNAL MEDICINE. 2016;279(3):211-228

Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.

Gülen T; Hägglund H; Dahlén B; Nilsson G
KI thesis / dissertation: 2014

Mast cell activation disorders : a liaison between anaphylaxis and mastocytosis

Gülen, Theo
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(9):1179-1187

The presence of mast cell clonality in patients with unexplained anaphylaxis.

Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
Editorial comment: LANCET. 2014;383(9928):1608

Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis.

Gülen T; Hägglund H; Dahlén S-E; Sander B; Dahlén B; Nilsson G
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(1):121-129

High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.

Gülen T; Hägglund H; Dahlén B; Nilsson G
Article: TRANSFUSION. 1999;39(6):593-598

FcgammaRIIIB polymorphism: evidence that NA1/NA2 and SH are located in two closely linked loci and that the SH allele is linked to the NA1 allele in the Danish population.

Steffensen R; Gülen T; Varming K; Jersild C
Visa fler

Artiklar

Journal article: CURRENT ALLERGY AND ASTHMA REPORTS. 2024;24(2):39-51

Using the Right Criteria for MCAS.

Gulen T
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2023;11(6):1706-1717

European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives.

Valent P; Hartmann K; Bonadonna P; Sperr WR; Niedoszytko M; Hermine O; Kluin-Nelemans HC; Sotlar K; Hoermann G; Nedoszytko B; Broesby-Olsen S; Zanotti R; Lange M; Doubek M; Brockow K; Alvarez-Twose I; Varkonyi J; Yavuz S; Nilsson G; Radia D; Grattan C; Schwaab J; Gülen T; Oude Elberink HNG; Hägglund H; Siebenhaar F; Hadzijusufovic E; Sabato V; Mayer J; Reiter A; Orfao A; Horny H-P; Triggiani M; Arock M
Journal article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2022;10(8):2015-2024

Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium.

Pyatilova P; Akin C; Alvarez-Twose I; Arock M; Bonadonna P; Brockow K; Butterfield JH; Broesby-Olsen S; Carter MC; Castells M; George TI; Gotlib J; Greiner G; Gülen T; Hartmann K; Hermine O; Horny H-P; Jawhar M; Lange M; Lyons JJ; Maurer M; Metcalfe DD; Nedoszytko B; Niedoszytko M; Orfao A; Reiter A; Schwaab J; Sotlar K; Sperr WR; Triggiani M; Valent P; Siebenhaar F
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2022;21:s108

P153 Hypersensitivity reactions to antibiotics in patients with cystic fibrosis

Kowalik A; de Monestrol I; Sorjonen K; Gülen T
Article: ACTA DERMATO-VENEREOLOGICA. 2016;96(5):602-612

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus.

Broesby-Olsen S; Dybedal I; Gülen T; Kristensen TK; Møller MB; Ackermann L; Sääf M; Karlsson MA; Agertoft L; Brixen K; Hermann P; Stylianou E; Mortz CG; Torfing T; Havelund T; Sander B; Bergström A; Bendix M; Garvey LH; Bjerrum OW; Valent P; Bindslev-Jensen C; Nilsson G; Vestergaard H; Hägglund H
Article: MEDICAL ONCOLOGY. 2014;31(8):123

Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis.

Hägglund H; Sander B; Ahmadi A; Gülen T; Nilsson G
Article: CLINICAL AND TRANSLATIONAL ALLERGY. 2013;3(1):22

The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.

Gülen T; Dahlén B; Sander B; Hägglund H; Nilsson G
Article: MEDICAL ONCOLOGY. 2012;29(5):3540-3546

Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm.

Gülen T; Sander B; Nilsson G; Palmblad J; Sotlar K; Horny H-P; Hägglund H
Article: LAKARTIDNINGEN. 2007;104(24-25):1881-1882

[Take advantage of the foreign physicians' experiences].

Shemais H; Hot-Bjelak A; Pavlakovic ST; Gülen T

Alla övriga publikationer

Letter: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2022;10(4):1128

Reply to "Need to define a subgroup of patients with idiopathic mast cell activation syndrome".

Gülen T; Akin C; Metcalfe DD; Valent P
Preprint: 2021;Authorea Preprints

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity

Nilsson G; Lyberg K; Ekoff M; Westerberg CM; Engblom C; Dahlen B; Gulen T
Review: CURRENT ALLERGY AND ASTHMA REPORTS. 2021;21(2):11

Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists.

Gulen T; Akin C
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(3):1454

A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders.

Romantowski J; Górska A; Niedoszytko M; Gulen T; Gruchała-Niedoszytko M; Nedoszytko B; Lange M; Brockow K; Arock M; Akin C; Valent P
Book chapter: 2020;p. 141-155

Anaphylaxis in Mastocytosis

Gülen T; Oude Elberink JNG; Brockow K
Editorial comment: ACTA DERMATO-VENEREOLOGICA. 2018;98(1):149-150

Pre-emptive Evaluation of Venom Allergy in a Patient with Systemic Mastocytosis.

Gülen T; Akin C
Conference publication: ALLERGY. 2017;72:445

Altered mast cell reactivity in patients with mastocytosis

Gulen T; Lyberg K; Westerberg MC; Ekoff M; Alexeyenko A; Dahlen B; Nilsson G
Review: LAKARTIDNINGEN. 2016;113:D7CI

[Insect venom allergy – the diagnosis can be difficult to make but good treatment is available].

Gülen T; Björkander J
Review: LAKARTIDNINGEN. 2016;113:DTED

[Anaphylaxis can be life-threatening, treatment must be initiated promptly].

Gülen T; Wickman M
Editorial comment: ACTA DERMATO-VENEREOLOGICA. 2014;94(5):583-584

Increased risk of malignant melanoma in patients with systemic mastocytosis?

Hägglund H; Sander B; Gülen T; Lindelöf B; Nilsson G
Editorial comment: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(9):1099

The Editor takes a closer look at some of this month's articles

Zhang X-Y; Ziyab A; Guelen T
Review: LAKARTIDNINGEN. 2012;109(9-10):474-477

[Systemic mastocytosis. Underestimated condition in patients with idiopathic anaphylaxis].

Gülen T; Gottberg L; Dahlén B; Nilsson G; Hägglund H
Review: LAKARTIDNINGEN. 2008;105(46):3341-3347

[Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital].

Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G
Review: LAKARTIDNINGEN. 2007;104(26-27):1982-1986

[Anaphylaxis--a potentially life-threatening systemic reaction. Immediate and adequate emergency treatment is of significance].

Gülen T; Gottberg L

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2024-2027
Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2014

Utvalda publikationer

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI